BIOMAT Database Logo BIOMAT Database Logo

[The efficacy of 2 new drug forms of isosorbide-5-mononitrate in patients with stable stenocardia of effort]. 1994

V I Metelitsa, and S Iu Martsevich, and N P Kutishenko, and M P Kozyreva, and S V Blagodatskikh, and L S Simkhaev, and I D Slastnikova, and M K Vakulovskaia

UI MeSH Term Description Entries
D007548 Isosorbide Dinitrate A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action. Cardonit 40,Dilatrate,Iso-Bid,Isodinit,Isoket,Isoket Retard-120,Isomak R,Isordil,Isotrate,Nitrosorbide,Sorbitrate,Sorbonit,Dinitrate, Isosorbide,Iso Bid,IsoBid,Isoket Retard 120,Isoket Retard120
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005080 Exercise Test Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used. Arm Ergometry Test,Bicycle Ergometry Test,Cardiopulmonary Exercise Testing,Exercise Testing,Step Test,Stress Test,Treadmill Test,Cardiopulmonary Exercise Test,EuroFit Tests,Eurofit Test Battery,European Fitness Testing Battery,Fitness Testing,Physical Fitness Testing,Arm Ergometry Tests,Bicycle Ergometry Tests,Cardiopulmonary Exercise Tests,Ergometry Test, Arm,Ergometry Test, Bicycle,Ergometry Tests, Arm,Ergometry Tests, Bicycle,EuroFit Test,Eurofit Test Batteries,Exercise Test, Cardiopulmonary,Exercise Testing, Cardiopulmonary,Exercise Tests,Exercise Tests, Cardiopulmonary,Fitness Testing, Physical,Fitness Testings,Step Tests,Stress Tests,Test Battery, Eurofit,Test, Arm Ergometry,Test, Bicycle Ergometry,Test, Cardiopulmonary Exercise,Test, EuroFit,Test, Exercise,Test, Step,Test, Stress,Test, Treadmill,Testing, Cardiopulmonary Exercise,Testing, Exercise,Testing, Fitness,Testing, Physical Fitness,Tests, Arm Ergometry,Tests, Bicycle Ergometry,Tests, Cardiopulmonary Exercise,Tests, EuroFit,Tests, Exercise,Tests, Step,Tests, Stress,Tests, Treadmill,Treadmill Tests
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

V I Metelitsa, and S Iu Martsevich, and N P Kutishenko, and M P Kozyreva, and S V Blagodatskikh, and L S Simkhaev, and I D Slastnikova, and M K Vakulovskaia
[Isosorbide 5-mononitrate (delayed release) in stable effort angina].
January 1992, Revista espanola de cardiologia,
V I Metelitsa, and S Iu Martsevich, and N P Kutishenko, and M P Kozyreva, and S V Blagodatskikh, and L S Simkhaev, and I D Slastnikova, and M K Vakulovskaia
Efficacy and safety of controlled-release isosorbide-5-mononitrate in Japanese patients with stable effort angina pectoris.
September 2006, International heart journal,
V I Metelitsa, and S Iu Martsevich, and N P Kutishenko, and M P Kozyreva, and S V Blagodatskikh, and L S Simkhaev, and I D Slastnikova, and M K Vakulovskaia
[Efficacy of isosorbide-5-mononitrate retard in patients with stable exertional angina].
January 2005, Klinicheskaia meditsina,
V I Metelitsa, and S Iu Martsevich, and N P Kutishenko, and M P Kozyreva, and S V Blagodatskikh, and L S Simkhaev, and I D Slastnikova, and M K Vakulovskaia
[Paired bicycle exercise test in assessment of clinical efficacy of isosorbide-5-mononitrate in patients with stable angina of effort].
January 2005, Kardiologiia,
V I Metelitsa, and S Iu Martsevich, and N P Kutishenko, and M P Kozyreva, and S V Blagodatskikh, and L S Simkhaev, and I D Slastnikova, and M K Vakulovskaia
[The anti-anginal efficacy of the drug forms of isosorbide-5-mononitrate--Monocinque, Monocinque retard and isosorbide dinitrate].
April 1997, Voenno-meditsinskii zhurnal,
V I Metelitsa, and S Iu Martsevich, and N P Kutishenko, and M P Kozyreva, and S V Blagodatskikh, and L S Simkhaev, and I D Slastnikova, and M K Vakulovskaia
[A new anti-ischemic drug for the treatment of stable effort angina pectoris: nicorandil. Comparison with placebo and isosorbide-5-mononitrate].
September 1991, Cardiologia (Rome, Italy),
V I Metelitsa, and S Iu Martsevich, and N P Kutishenko, and M P Kozyreva, and S V Blagodatskikh, and L S Simkhaev, and I D Slastnikova, and M K Vakulovskaia
[Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
March 1985, Giornale italiano di cardiologia,
V I Metelitsa, and S Iu Martsevich, and N P Kutishenko, and M P Kozyreva, and S V Blagodatskikh, and L S Simkhaev, and I D Slastnikova, and M K Vakulovskaia
The efficacy of isosorbide-5-mononitrate on effort-induced electrocardiographic ischemic changes in patients with angina pectoris.
September 1987, International journal of cardiology,
V I Metelitsa, and S Iu Martsevich, and N P Kutishenko, and M P Kozyreva, and S V Blagodatskikh, and L S Simkhaev, and I D Slastnikova, and M K Vakulovskaia
Saliva concentrations of isosorbide dinitrate, isosorbide 2-mononitrate and isosorbide 5-mononitrate.
May 1984, British journal of clinical pharmacology,
V I Metelitsa, and S Iu Martsevich, and N P Kutishenko, and M P Kozyreva, and S V Blagodatskikh, and L S Simkhaev, and I D Slastnikova, and M K Vakulovskaia
Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
December 1993, The American journal of cardiology,
Copied contents to your clipboard!